← Eichor
Condition: Diabetic Macular Edema Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Diabetic Macular Edema

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Gene Therapy for Diabetic Macular Edema
Phase 1 · 1 location(s) · Frontera Therapeutics · NCT05916391Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME)
Phase 2 · 1 location(s) · Sierra Eye Associates · NCT06942520Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab
NA · 1 location(s) · Osijek University Hospital · NCT07520045High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy
Phase 4 · 1 location(s) · Retina Consultants of Orange County · NCT06662994CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Phase 3 · 68 location(s) · EyePoint Pharmaceuticals, Inc. · NCT07449923A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Phase 1/Phase 2 · 30 location(s) · Boehringer Ingelheim · NCT07553429A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Phase 2 · 80 location(s) · Boehringer Ingelheim · NCT06962839Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy
NA · 1 location(s) · Vastra Gotaland Region · NCT06549023Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema
Phase 2 · 1 location(s) · Alexandria University · NCT06845163Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin
Phase 2/Phase 3 · 1 location(s) · Isfahan University of Medical Sciences · NCT06595355A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema
Phase 3 · 1 location(s) · Incepta Pharmaceuticals Ltd · NCT06305416Non-Center Involving Diabetic Macular Edema Progression in Early Postoperative Period After Phacoemulsification
Phase N/A · 1 location(s) · Ain Shams University · NCT07038967EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema
Phase 1/Phase 2 · 1 location(s) · Eclipse Life Sciences, Inc. · NCT06536491Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Phase 1 · 5 location(s) · Ocugen · NCT05802329Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant
NA · 2 location(s) · Vastra Gotaland Region · NCT06984822Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and R
Phase N/A · 1 location(s) · Hywel Dda Health Board · NCT06914778COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Phase 3 · 70 location(s) · EyePoint Pharmaceuticals, Inc. · NCT07449936Acute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL
NA · 1 location(s) · Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · NCT06893965Effect of Video Viewing on Intravitreal Injection Experience
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07002372Gene Therapy for DME
Phase 1/Phase 2 · 1 location(s) · Frontera Therapeutics · NCT06492876Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular
Phase 4 · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT04910503Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema
Phase N/A · 1 location(s) · The General Authority for Teaching Hospitals and Institutes · NCT07295704Home- vs Hospital-based Care of Anti-VEGF Treatment for Diabetic Macular Edema: Non-inferiority RCT
NA · 4 location(s) · Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT06610747Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without C
Phase 2/Phase 3 · 15 location(s) · AbbVie · NCT07592273Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Dia
NA · 1 location(s) · Tianjin Medical University Eye Hospital · NCT05728476A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.
Phase 1 · 7 location(s) · Therini Bio Pty Ltd · NCT06701721Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients
EARLY_Phase 1 · 2 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT07362927Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema
Phase 3 · 50 location(s) · Bio-Thera Solutions · NCT07515079A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects with DME
Phase 2 · 1 location(s) · EnnovaBio · NCT06708260A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With D
Phase 1 · 10 location(s) · Genentech, Inc. · NCT07425522
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.